{"cluster": 45, "subcluster": 6, "abstract_summ": " There is growing evidence that pulmonary embolism and thrombosis contribute to adverse outcomes and increased mortality in critically ill patients with COVID-19 . There is a risk of delayed thromboembolic complications in patients with the disease, even after recovery . We aim to provide advice to establish an improved and more uniform strategy for patients ."}